Semiquantitative assessment of CD45 positivity showed comparable levels to the one observed in biopsies from patients classifiable as SSc according to the 2013 criteria (Fig. 3B, Supplementary Fig. S5B, available at Rheumatology online). This evidence concerns the gene PTPRC and systemic sclerosis.